Advisors Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.5M Sell
103,779
-3,101
-3% -$1.11M 0.61% 18
2025
Q4
$35M Sell
106,880
-3,110
-3% -$987K 0.59% 17
2025
Q3
$31M Sell
109,990
-2,136
-2% -$619K 0.53% 20
2025
Q2
$31.3M Sell
112,126
-2,426
-2% -$687K 0.56% 18
2025
Q1
$35.7M Buy
114,552
+4,106
+4% +$1.21M 0.67% 14
2024
Q4
$28.8M Sell
110,446
-1,046
-0.9% -$310K 0.53% 20
2024
Q3
$35.9M Sell
111,492
-2,325
-2% -$761K 0.66% 17
2024
Q2
$35.6M Sell
113,817
-3,653
-3% -$1.07M 0.69% 15
2024
Q1
$33.4M Buy
117,470
+11,104
+10% +$3.25M 0.64% 19
2023
Q4
$30.6M Buy
106,366
+17,719
+20% +$4.83M 0.63% 20
2023
Q3
$23.8M Sell
88,647
-5,550
-6% -$1.39M 0.51% 29
2023
Q2
$20.9M Sell
94,197
-2,469
-3% -$573K 0.43% 41
2023
Q1
$23.4M Sell
96,666
-2,865
-3% -$703K 0.48% 39
2022
Q4
$26.1M Sell
99,531
-9,952
-9% -$2.67M 0.54% 35
2022
Q3
$24.7M Sell
109,483
-22,911
-17% -$5.55M 0.52% 30
2022
Q2
$32.2M Sell
132,394
-799
-0.6% -$196K 0.61% 26
2022
Q1
$32.2M Buy
133,193
+17,113
+15% +$3.93M 0.5% 29
2021
Q4
$26.1M Buy
116,080
+14,318
+14% +$3.02M 0.37% 44
2021
Q3
$21.6M Buy
101,762
+12,467
+14% +$2.87M 0.33% 53
2021
Q2
$21.8M Buy
89,295
+30,713
+52% +$7.56M 0.32% 53
2021
Q1
$14.6M Buy
58,582
+7,228
+14% +$1.72M 0.23% 80
2020
Q4
$11.8M Buy
51,354
+1,132
+2% +$261K 0.2% 96
2020
Q3
$12.8M Sell
50,222
-4,915
-9% -$1.22M 0.24% 75
2020
Q2
$13M Sell
55,137
-4,587
-8% -$1.05M 0.25% 72
2020
Q1
$12.1M Sell
59,724
-6,607
-10% -$1.44M 0.29% 72
2019
Q4
$16M Buy
66,331
+292
+0.4% +$64.4K 0.28% 80
2019
Q3
$12.8M Sell
66,039
-422
-0.6% -$81K 0.24% 90
2019
Q2
$12.2M Sell
66,461
-3,613
-5% -$647K 0.22% 95
2019
Q1
$13.3M Sell
70,074
-3,859
-5% -$737K 0.24% 96
2018
Q4
$14.4M Buy
73,933
+1,418
+2% +$277K 0.29% 77
2018
Q3
$15M Buy
72,515
+3,107
+4% +$612K 0.25% 101
2018
Q2
$12.8M Buy
69,408
+719
+1% +$127K 0.22% 110
2018
Q1
$12.6M Sell
68,689
-1,294
-2% -$238K 0.21% 111
2017
Q4
$12.2M Buy
69,983
+8,467
+14% +$1.5M 0.2% 125
2017
Q3
$11.5M Sell
61,516
-8,791
-13% -$1.56M 0.19% 132
2017
Q2
$12.1M Buy
70,307
+5,550
+9% +$903K 0.2% 121
2017
Q1
$10.6M Sell
64,757
-1,326
-2% -$220K 0.18% 146
2016
Q4
$9.66M Buy
66,083
+5,670
+9% +$853K 0.16% 165
2016
Q3
$10.1M Sell
60,413
-7,285
-11% -$1.23M 0.17% 166
2016
Q2
$10.3M Buy
67,698
+8,500
+14% +$1.32M 0.17% 170
2016
Q1
$8.88M Sell
59,198
-9,088
-13% -$1.35M 0.15% 196
2015
Q4
$11.1M Buy
68,286
+5,597
+9% +$880K 0.18% 158
2015
Q3
$8.67M Sell
62,689
-583
-0.9% -$91.9K 0.14% 209
2015
Q2
$9.71M Buy
63,272
+604
+1% +$96.8K 0.13% 208
2015
Q1
$10M Sell
62,668
-802
-1% -$126K 0.13% 201
2014
Q4
$10.1M Buy
63,470
+5,452
+9% +$850K 0.14% 194
2014
Q3
$8.15M Buy
58,018
+5,946
+11% +$776K 0.11% 228
2014
Q2
$6.16M Buy
52,072
+4,657
+10% +$539K 0.09% 282
2014
Q1
$5.85M Buy
47,415
+8,383
+21% +$1.02M 0.09% 285
2013
Q4
$4.46M Buy
39,032
+5,085
+15% +$578K 0.07% 340
2013
Q3
$3.8M Buy
33,947
+10,780
+47% +$1.17M 0.07% 353
2013
Q2
$2.29M Buy
+23,167
New +$2.4M 0.04% 434

Other funds holding AMGN

Advisors Asset Management's AMGN Position: Q1 2026 in Review

Advisors Asset Management reduced its Amgen (AMGN) stake by 2.9% in Q1 2026, selling an estimated $1.11M and leaving 103,779 shares worth $36.5M. The position accounts for 0.61% of the portfolio, ranked #18.

Advisors Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Advisors Asset Management held 103,779 shares of Amgen worth $36.5M as of Q1 2026.
  • Advisors Asset Management sold 3,101 Amgen shares in Q1 2026, an estimated $1.11M.
  • Amgen made up 0.61% of Advisors Asset Management's portfolio in Q1 2026, its #18 holding.
  • Advisors Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.